BMDI Releases MAXAIR 710DLC CAPR, A Merging of Respirator Technologies
Respiratory protection in healthcare traditionally follows two technology paths, mask respirators (N95s) and powered air purifying respirators (PAPRs).
Bio-Medical Devices Intl. recognized that health-related events this decade and world economics underscore the need for a respirator that not only integrates the best features of both technologies, but also improves on them.
N95s provide lower protection due to filtration efficiency and poor fit, low user tolerance due to breathing resistance, heat and moisture buildup, and pressure points against the face, and high life-cycle cost due to need for stocking many types and sizes and the time and cost burden of annual fit-testing.
Conventional PAPRs are bulky, interfere with maneuverability, lack real-time safe operation status indicators, are difficult and time-consuming to de-con, and have high product cost and high life-cycle cost of disposables.
Healthcare workers demand a more tolerable respirator, comfortable and convenient, to facilitate use compliance. They need higher protection without the cost and burden of annual fit-testing. They need a respirator quick and easy to don and doff and that is compact to allow quick movement between patients without restriction. They need a combination of the disposable advantages that the N95 was to have and the reusable conveniences PAPRs were supposed to provide -- a merging of the technologies.
BMDI accomplished "the merge" with the MAXAIR 710-DLC CAPR.
Comfortable, light-weight integrated helmet
--No air-tube hose or bulky blower unit -- freedom of movement.
-- Increased comfort for all activities.
-- Reduced connections and uneven surfaces - easier and quicker de-con between uses.
-- Always visible, peripheral vision LEDs -- real-time safe airflow and battery charge indication.
Unique DLC, disposable lens-cuff
-- Easier and quicker to don and doff than N95s.
-- Superior filtration protection no annual fit-testing.
-- Cost comparable to N95 and goggles.
CAPR provides safety, convenience, and comfort for high compliance use and optimal protection for low to high-risk challenges during infectious patient care.
MAXAIR CAPR is the optimum daily use respirator, highly deployable, with a life-cycle cost more advantageous than N95s or conventional PAPRs.
For more information, visit www.maxair-systems.com
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
